Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.

Molecular oncology - 1 Mar 2016

Riva Francesca, Dronov Oleksii I, Khomenko Dmytro I, Huguet Florence, Louvet Christophe, Mariani Pascale, Stern Marc-Henri, Lantz Olivier, Proudhon Charlotte, Pierga Jean-Yves, Bidard Francois-Clement

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) is the most frequent pancreatic cancer type and is characterized by a dismal prognosis due to late diagnosis, local tumor invasion, frequent distant metastases and poor sensitivity to current therapy. In this context, circulating tumor cells and circulating tumor DNA constitute easily accessible blood-borne tumor biomarkers that may prove their clinical interest for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Pancreatic Ductal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Epithelial-Mesenchymal Transition

Share to Neoplasm Metastasis

Share to Neoplastic Cells, Circulating

Share to Pancreatic Ducts

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26856794
DOI: 10.1016/j.molonc.2016.01.006
PMCID: PMC5528974

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.PMID 26856794Read ↗

Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.Semantic proximity Read ↗

Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Current status of molecular diagnostic approaches using liquid biopsy.Semantic proximity Read ↗

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic CancerSemantic proximity Read ↗

Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics-A Review.Semantic proximity Read ↗

Liquid biopsy in pancreatic cancer: the beginning of a new eraSemantic proximity Read ↗

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas.Semantic proximity Read ↗

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasisSemantic proximity Read ↗

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.Semantic proximity Read ↗

Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.Semantic proximity Read ↗

Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.Semantic proximity Read ↗

Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.